CLINICAL_TRIALS
trial_result
· 2008-09-05
Clinical Trial Update: Study Evaluating the Bioavailability of Naproxen 375 mg in Two Formulations [Phase 1]
Summary
A Phase 1 study evaluated the bioavailability of naproxen 375 mg across two formulations in individuals with arthritis; the trial has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: POZEN | Conditions: Arthritis | Phase 1 | Status: COMPLETED